Explore

Trendline Trendline
CytoSorbents Reports Increased Revenue Amidst Financial Losses in Q1 2026

CytoSorbents Reports Increased Revenue Amidst Financial Losses in Q1 2026

CytoSorbents Reports Increased Revenue Amidst Financial Losses in Q1 2026
Trendline Trendline
VentriPoint Diagnostics Expands Global Footprint with AI-Powered Cardiac Imaging

VentriPoint Diagnostics Expands Global Footprint with AI-Powered Cardiac Imaging

VentriPoint Diagnostics Expands Global Footprint with AI-Powered Cardiac Imaging
Trendline Trendline
Johnson Johnson Launches Enhanced Shockwave Catheter to Improve Treatment of Calcified Lesions

Johnson Johnson Launches Enhanced Shockwave Catheter to Improve Treatment of Calcified Lesions

Johnson Johnson Launches Enhanced Shockwave Catheter to Improve Treatment of Calcified Lesions
Trendline Trendline
Koya Medical to Showcase Innovations at May 2026 Investor Conferences

Koya Medical to Showcase Innovations at May 2026 Investor Conferences

Koya Medical to Showcase Innovations at May 2026 Investor Conferences
Trendline Trendline
Anteris Technologies Initiates US Enrolment for PARADIGM Trial with Significant Funding

Anteris Technologies Initiates US Enrolment for PARADIGM Trial with Significant Funding

Anteris Technologies Initiates US Enrolment for PARADIGM Trial with Significant Funding
Trendline Trendline
Anteris Technologies Initiates US PARADIGM Trial Enrolment with Significant Funding Boost

Anteris Technologies Initiates US PARADIGM Trial Enrolment with Significant Funding Boost

Anteris Technologies Initiates US PARADIGM Trial Enrolment with Significant Funding Boost
Trendline Trendline
Roche's New Alzheimer's Blood Test Receives CE Mark, Promises Faster Diagnosis

Roche's New Alzheimer's Blood Test Receives CE Mark, Promises Faster Diagnosis

Roche's New Alzheimer's Blood Test Receives CE Mark, Promises Faster Diagnosis
Trendline Trendline
Anteris Technologies Initiates US PARADIGM Trial Enrolment Amid Financial Challenges

Anteris Technologies Initiates US PARADIGM Trial Enrolment Amid Financial Challenges

Anteris Technologies Initiates US PARADIGM Trial Enrolment Amid Financial Challenges
Trendline Trendline
Cleveland Diagnostics Achieves ISO Certification, Paving Way for IsoPSA Assay Expansion

Cleveland Diagnostics Achieves ISO Certification, Paving Way for IsoPSA Assay Expansion

Cleveland Diagnostics Achieves ISO Certification, Paving Way for IsoPSA Assay Expansion
Trendline Trendline
Avenacy Launches Ready-to-Use Tranexamic Acid Injection in U.S. Market

Avenacy Launches Ready-to-Use Tranexamic Acid Injection in U.S. Market

Avenacy Launches Ready-to-Use Tranexamic Acid Injection in U.S. Market
Trendline Trendline
Corvention Secures FDA Clearance for KardiaPSI Balloon Catheter, Enhancing Aortic Valve Procedures

Corvention Secures FDA Clearance for KardiaPSI Balloon Catheter, Enhancing Aortic Valve Procedures

Corvention Secures FDA Clearance for KardiaPSI Balloon Catheter, Enhancing Aortic Valve Procedures
Trendline Trendline
LIB Therapeutics Launches LEROCHOL in the U.S. with Focus on Affordability

LIB Therapeutics Launches LEROCHOL in the U.S. with Focus on Affordability

LIB Therapeutics Launches LEROCHOL in the U.S. with Focus on Affordability